In the BioHarmony Drug Report Database
Erythromycin
Akne-mycin, Eryc, Eryc Sprinkles, Erycette, Erygel, Erythromycin, Ilotycin, Pce, Staticin (erythromycin) is a small molecule pharmaceutical. Erythromycin was first approved as Akne-mycin on 1982-01-01. It is used to treat acne vulgaris, bacterial eye infections, bacterial infections, campylobacter infections, and chancroid amongst others in the USA. It is known to target motilin receptor.
Trade Name
|
Akne-mycin, Eryc, Eryc Sprinkles, Erycette, Erygel, Erythromycin, Ilotycin, Pce, Staticin |
|---|---|
Common Name
|
erythromycin |
ChEMBL ID
|
CHEMBL532 |
Indication
|
acne vulgaris, bacterial eye infections, bacterial infections, campylobacter infections, chancroid, chlamydia infections, erythrasma, gastroenteritis, gonorrhea, legionnaires' disease, mycoplasma infections, protozoan infections, staphylococcal infections, streptococcal infections, syphilis, urethritis, whooping cough |
Drug Class
|
Antibiotics (Streptomyces strains) |
Image (chem structure or protein)